297 related articles for article (PubMed ID: 12954067)
21. Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mazumder A; Neamati N; Sommadossi JP; Gosselin G; Schinazi RF; Imbach JL; Pommier Y
Mol Pharmacol; 1996 Apr; 49(4):621-8. PubMed ID: 8609889
[TBL] [Abstract][Full Text] [Related]
22. A novel imidazole nucleoside containing a diaminodihydro-S-triazine as a substituent: inhibitory activity against the West Nile virus NTPase/helicase.
Ujjinamatada RK; Agasimundin YS; Zhang P; Hosmane RS; Schuessler R; Borowski P; Kalicharran K; Fattom A
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1775-88. PubMed ID: 16438047
[TBL] [Abstract][Full Text] [Related]
23. Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme.
Borowski P; Niebuhr A; Mueller O; Bretner M; Felczak K; Kulikowski T; Schmitz H
J Virol; 2001 Apr; 75(7):3220-9. PubMed ID: 11238848
[TBL] [Abstract][Full Text] [Related]
24. Excision of incorporated nucleotide analogue chain-terminators can diminish their inhibitory effects on viral RNA-dependent RNA polymerases.
D'Abramo CM; Cellai L; Götte M
J Mol Biol; 2004 Mar; 337(1):1-14. PubMed ID: 15001348
[TBL] [Abstract][Full Text] [Related]
25. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
[TBL] [Abstract][Full Text] [Related]
26. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
Borowski P; Lang M; Haag A; Baier A
Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
[TBL] [Abstract][Full Text] [Related]
27. DNA helicase activity of the hepatitis C virus nonstructural protein 3.
Gwack Y; Kim DW; Han JH; Choe J
Eur J Biochem; 1997 Nov; 250(1):47-54. PubMed ID: 9431989
[TBL] [Abstract][Full Text] [Related]
28. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.
Wardell AD; Errington W; Ciaramella G; Merson J; McGarvey MJ
J Gen Virol; 1999 Mar; 80 ( Pt 3)():701-709. PubMed ID: 10092010
[TBL] [Abstract][Full Text] [Related]
29. Methods for detecting ATP hydrolysis and nucleic acid unwinding of Japanese encephalitis virus NS3 helicase.
Fang J; Li H; Peng G; Cao S; Zhen FF; Chen H; Song Y
J Virol Methods; 2013 Dec; 194(1-2):33-8. PubMed ID: 23948158
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease.
Crute JJ; Grygon CA; Hargrave KD; Simoneau B; Faucher AM; Bolger G; Kibler P; Liuzzi M; Cordingley MG
Nat Med; 2002 Apr; 8(4):386-91. PubMed ID: 11927945
[TBL] [Abstract][Full Text] [Related]
31. High-throughput screening assay of hepatitis C virus helicase inhibitors using fluorescence-quenching phenomenon.
Tani H; Akimitsu N; Fujita O; Matsuda Y; Miyata R; Tsuneda S; Igarashi M; Sekiguchi Y; Noda N
Biochem Biophys Res Commun; 2009 Feb; 379(4):1054-9. PubMed ID: 19150342
[TBL] [Abstract][Full Text] [Related]
32. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and in vitro anti-hepatitis B and C virus activities of ring-expanded ('fat') nucleobase analogues containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system.
Zhang P; Zhang N; Korba BE; Hosmane RS
Bioorg Med Chem Lett; 2005 Dec; 15(24):5397-401. PubMed ID: 16213713
[TBL] [Abstract][Full Text] [Related]
34. Human DEAD-box ATPase DDX3 shows a relaxed nucleoside substrate specificity.
Franca R; Belfiore A; Spadari S; Maga G
Proteins; 2007 Jun; 67(4):1128-37. PubMed ID: 17357160
[TBL] [Abstract][Full Text] [Related]
35. Dual inhibition of HCV and HIV by ring-expanded nucleosides containing the 5:7-fused imidazo[4,5-e][1,3]diazepine ring system. In vitro results and implications.
Zhang N; Zhang P; Baier A; Cova L; Hosmane RS
Bioorg Med Chem Lett; 2014 Feb; 24(4):1154-7. PubMed ID: 24461293
[TBL] [Abstract][Full Text] [Related]
36. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy.
Borowski P; Schalinski S; Schmitz H
Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the West Nile virus protease substrate specificity and inhibitors.
Mueller NH; Yon C; Ganesh VK; Padmanabhan R
Int J Biochem Cell Biol; 2007; 39(3):606-14. PubMed ID: 17188926
[TBL] [Abstract][Full Text] [Related]
38. [Comparison and discrimination of the biological characteristics between West Nile virus and Japanese encephalitis virus].
Zhang JS; Zhang PH; Si BY; Yang H; Cao WC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Dec; 19(4):340-3. PubMed ID: 16415991
[TBL] [Abstract][Full Text] [Related]
39. Substrate/inhibition studies of bacteriophage T7 RNA polymerase with the 5'-triphosphate derivative of a ring-expanded ('fat') nucleoside possessing potent antiviral and anticancer activities.
Bretner M; Beckett TD; Sood RK; Baldisseri DM; Hosmane RS
Bioorg Med Chem; 1999 Dec; 7(12):2931-6. PubMed ID: 10658598
[TBL] [Abstract][Full Text] [Related]
40. Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42.
Lin CW; Cheng CW; Yang TC; Li SW; Cheng MH; Wan L; Lin YJ; Lai CH; Lin WY; Kao MC
Virus Res; 2008 Oct; 137(1):49-55. PubMed ID: 18588927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
